GlassScriptPhysician profile
Abilash K Haridas
NPI 1326200122
$17,762.81
in general payments reported to CMS, 2019-2025
15 companies · $462 in 2025
The $462 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,710 · 2020: $19.28 · 2021: $464 · 2022: $14K · 2023: $52.38 · 2024: $6.44 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $13,898.03 | 2019-2022 | |
| Globus Medical, INC. | $2,410.31 | 2019-2025 | Excelsius Gps |
| Livanova USA, INC. | $261.27 | 2019-2022 | |
| Penumbra, INC. | $242.15 | 2019-2022 | |
| Depuy Synthes Sales INC. | $201.73 | 2022-2023 | Synthecel |
| Medtronic, INC. | $150.56 | 2021-2025 | Mazor X System |
| Microvention, INC. | $143.79 | 2019 | |
| Dompe US, INC. | $106.09 | 2025 | Oxervate |
| Boston Scientific Corporation | $97.84 | 2025 | Wavewriter Alpha Prime 16 |
| Philips North America LLC | $86.29 | 2025 | Azurion 7 M20 |
| Medical Device Business Services, INC. | $83.15 | 2022 | |
| Stryker Corporation | $33.38 | 2025 | Spinejack |
| Ethicon US, LLC | $22.50 | 2022 | |
| Portola Pharmaceuticals, LLC | $19.28 | 2020 | |
| Corium, LLC | $6.44 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abilash Haridas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.